GPCR
NASDAQ
US
Structure Therapeutics Inc. - American Depositary Shares
$53,48
▲ +$3,31
(+6,60%)
Vol. 1.7M
3
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$4.2B
ROE
-26,1%
D/E
0,00
Beta
-2,10
52W
$13–$95
Consenso Wall Street
23 analisti · Apr 20268
Acquisto forte
13
Compra
2
Mantieni
0
Vendi
0
Vendita forte
91,3%
Rating Compra
Grafico dei Prezzi
Titoli simili
CORT
Corcept Therapeutics Inc
P/E 34,5
$3.7B
LGND
Ligand Pharmaceuticals Inc
P/E 76,6
$3.7B
AMRX
Amneal Pharmaceuticals Inc
P/E 671,4
$4.0B
CRNX
Crinetics Pharmaceuticals Inc
$4.4B
INDV
Indivior Pharmaceuticals, Inc
P/E 35,8
$4.5B
EWTX
Edgewise Therapeutics Inc
$2.6B
LQDA
Liquidia Corp
$3.0B
TARS
Tarsus Pharmaceuticals Inc
$3.5B
SUPN
Supernus Pharmaceuticals Inc
$2.8B
ALMS
Alumis Inc
$1.0B
Utili
Tasso di battuta: 0,0%
Prossimo report
Mag 06, 2026
Stima EPS: $-0,36
| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Mar 2026 | $-0,36 | — | — |
| Dic 2025 | $-0,47 | $-1,22 | $-0,75 |
| Set 2025 | $-0,36 | $-1,11 | $-0,75 |
| Giu 2025 | $-0,28 | $-1,08 | $-0,80 |
Ricavi e utili trimestrali
| Trimestre | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Ricavi | — | — | — | — | — |
| Utile netto | -$36.5M | -$46.8M | -$61.7M | -$65.7M | $33.0M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -21.3% | -21.3% | -21.3% | -21.3% | -26.1% | -26.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 20.48 | 20.48 | 20.48 | 20.48 | 14.15 | 14.15 |
Rapporti chiave
ROA (TTM)
-24,7%
P/B
1,8
EPS (TTM)
$-1,22
CF/Share
$-2,24
52W High
$94,90
52W Low
$13,22
$13,22
Intervallo 52 settimane
$94,90
Salute finanziaria
Flusso di cassa libero
-$65.9M
Debito netto
-$793.1M
Liquidità
$799.6M
Debito totale
$6.5M
Aggiornato al Dic 31, 2025
Як GPCR виглядає на тлі конкурентів у Pharmaceuticals?
Група порівняння: Mid-cap Pharmaceuticals ($2B+) · 25 компаній
Оцінка GPCR vs аналоги Pharmaceuticals
P/E
—
▼
0%
sotto
peer
(30,7)
vs Peer
vs Settore
Valore equo
P/S
—
▼
0%
sotto
peer
(6,7)
vs Peer
vs Settore
Sopravvalutato
P/B
1,8
▼
66%
sotto
peer
(5,2)
vs Peer
vs Settore
Sottovalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(3,1%)
vs Peer
vs Settore
Rendimento basso
Прибутковість GPCR vs аналоги Pharmaceuticals
ROE
-26,1%
▲
0%
sopra
peer
(-26,1%)
vs Peer
vs Settore
In linea
Net margin
—
▼
0%
sotto
peer
(-1,5%)
vs Peer
vs Settore
Top livello
Валова маржа
—
▼
0%
sotto
peer
(88,9%)
vs Peer
vs Settore
Top livello
ROA
-24,7%
▼
161%
sotto
peer
(-9,5%)
vs Peer
vs Settore
Debole
Фінансове здоровʼя GPCR vs аналоги Pharmaceuticals
D/E ratio
0,0
▼
100%
sotto
peer
(27,4)
vs Peer
vs Settore
Debito basso
Поточна ліквідність
14,2
▲
307%
sopra
peer
(3,5)
vs Peer
vs Settore
Liquidità forte
Beta
-2,1
▼
456%
sotto
peer
(0,6)
vs Peer
vs Settore
Più volatile
Радар фундаменталів GPCR
GPCR
Mediana peer
Industria
GPCR прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
GPCR vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
STEVENS RAYMOND C
Chief Executive Officer · Mar 19
260217 shs
HALL ASHLEY
Officer · Mar 19
47706 shs
MA YINGLI
Chief Technology Officer · Mar 19
32526 shs
LIN XICHEN
Officer · Mar 19
43368 shs
YOON JUN
Chief Financial Officer · Mar 19
104085 shs
COLL CRESPO BLAS
Officer · Mar 19
75897 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 44,59%FMR, LLC
12,30%
$397.8M
Wellington Management Group…
10,05%
$325.2M
Avoro Capital Advisors LLC
9,25%
$299.3M
Janus Henderson Group PLC
7,19%
$232.4M
Deep Track Capital, Lp
5,80%
$187.7M
Aggiornato al Dic 31, 2025